Advanced searches left 3/3

Anastrozole - Europe PMC

Summarized by Plex Scholar
Last Updated: 07 October 2022

* If you want to update the article please login/register

Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer.

Aromatase inhibitors improve survival for postmenopausal women with hormone receptor-positive breast cancer in a way, but also suffer patients with symptoms, which is a major reason for suboptimal AI adherence. This report establishes inter-relationships among symptom severity measures; discusses neuropsychological trajectories; and pinpoints trajectory group membership predictors for postmenopausal women administered anastrozole for HR + BC. Four neuropsychological scales/subscales were rescaled and averaged into a neuropsychological symptom burden assessment, with higher scores indicating higher symptoms of increased symptom burden. Results Women averaged 61 years old, mainly White, and were diagnosed with stage I HR + BC. Conclusion This report found correlations between neuropsychological symptom measures and self-reported NSBs with pre-anastrozole predictors. Identifying symptom trajectories and their predictors at pre-anastrozole can aid in health care and education of women with HR+ BC.

Source link: https://europepmc.org/article/MED/36085422

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions